MELBOURNE, Australia--(BUSINESS WIRE)--KarmelSonix (ASX: KSX), an emerging leader in the Acoustic Asthma Management market, announced today that the American Medical Association (AMA) has awarded two new Category III Current Procedural Terminology (CPT®1) Codes for use with KSX’s Acoustic Respiratory Monitoring technology.
